Abstract:Objective To analyze the effect of Deferoxamine Mesylate on hypertensive intracerebral hemorrhage.Methods A total of 113 patients with hypertensive intracerebral hemorrhage treated in our hospital from January to December 2017 were selected as study objects and they were divided into two groups according to the random digital table method,which were the control group(53 cases)and the study group(60 cases).The control group received the routine treatment.The study group was treated with Deferoxamine Mesylate on the basis of routine treatment.The relative edema volume,relative hematoma volume and prognosis at different time points(7,14 days after treatment)were analyzed.Results At 7,14 days after treatment,the relative edema volume and relative hematoma volume in the study group were less than those in the control group,the differences were statistically significant(P<0.05).At 7,14 days after treatment,the NIHSS scores of the study group were lower than those of the control group (P<0.05).And the relative edema volume and relative blood of 14 days after treatment in the study group were less than those of 7 days after treatment,the differences were statistically significant(P<0.05).The NASS score of 14 days after treatment in the study group and the control group were lower than those of 7 d after treatment,and the differences were statistically significant(P<0.05).Conclusion The application of Deferoxamine Mesylate in the treatment of hypertensive intracerebral hemorrhage is significant.It can not only reduce the volume of relative hematoma,but also effectively reduce the volume of relative edema,and help to promote the recovery of nerve function and the prognosis is good.